Roche skin cancer drug meets main goal in combination study

[riky]

Roche skin cancer drug meets main goal in combination study

<p><a href="http://news.yahoo.com/roche-skin-cancer-drug-meets-main-goal-combination-064952802--finance.html"><img src="http://l3.yimg.com/bt/api/res/1.2/FLtFQL5h8vW9eZpw0pg70w--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-07-14T064952Z_1_LYNXMPEA6D0AU_RTROPTP_2_SWITZERLAND.JPG" width="130" height="86" alt="The logo of Swiss pharmaceutical company Roche is seen at a plant in the central Swiss village of Rotkreuz" align="left" title="The logo of Swiss pharmaceutical company Roche is seen at a plant in the central Swiss village of Rotkreuz" border="0" /></a>An experimental drug from Roche helped people with an advanced form of skin cancer live longer without their disease worsening when used in combination with another treatment, the Swiss drugmaker said on Monday. Pharmaceutical companies are looking to combination therapy to yield better results and drug cocktails are expected to be crucial as oncologists seek to block cancer on multiple fronts. Cobimetinib, which is being developed in collaboration with Exelixis Inc, is designed to be used with another Roche drug called Zelboraf for patients with tumors that have a mutation in a gene known as BRAF that allows melanoma cells to grow.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login